CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$24.33
+5.51% today
Updated 2026-04-30
Market cap
$403.98M
P/E ratio
—
P/S ratio
0.42x
EPS (TTM)
$-17.30
Dividend yield
—
52W range
$12 – $74
Volume
0.2M
Claritev Corporation (CTEV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$24.33
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$82.67
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.0B | $0.9B | $1.0B | $1.0B | $1.0B | $1.0B | $1.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 0.58% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -29.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.